MedPath

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension

Completed
Conditions
Essential Hypertension
Registration Number
NCT01127139
Lead Sponsor
Abbott
Brief Summary

The fixed combination of verapamil SR/trandolapril (Tarka®) is an effective, well-tolerated therapy for the treatment of essential hypertension in those who require more than one agent to achieve optimal blood pressure (BP) control. The endpoint is compliance with Tarka® treatment by number/percentage of patients continued on fixed combination Tarka therapy after six months. This Post Marketing Observational Study will be conducted in a prospective, single-arm, single-country, multicenter format. The investigational sites will be the cardiologists, the doctors of internal medicine and general practicians. Since this will be a Post Marketing Observational Study, Tarka® will be prescribed in usual manner in accordance with the terms of the local market authorization with regards to dose, population and indication as well as the local guidelines.

Detailed Description

Follow-up of patients enables 4 patient visits during this period. For these reasons, the most likely visits are defined as "Inclusion visit" at which treatment with Tarka® is to be initiated, and then "Follow-up visit Week 4-6", "Follow-up visit Month 3 " and "Follow-up visit Month 6", although dates will depend only on the decision of the physician. For these reasons, the most likely visits are defined as "S/V" (Screening Visit), "F1" (Follow-up 1), "F2" (Follow-up 2), "F3" (Follow-up 3). The end point is compliance with Tarka® treatment by number/percentage of patients continued on fixed combination Tarka therapy after six months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3828
Inclusion Criteria
  • Men, women more than 18 years
  • Patients with uncontrolled essential hypertension eligible to Tarka treatment according to local label (BP ≥ 140/90 mmHg)
  • Patients providing oral informed consent (including consent of their medical data to be used for a Post Marketing Observational Study) and cooperating with physician
  • Patients who never received Tarka® in the past
  • Patients whom Tarka® will be prescribed according to the labelled indication and dose
Exclusion Criteria
  • Patients contraindicated for treatment of Tarka® according to the local Summary of Product Characteristics (SmPC):
  • Hypersensitive to the active substances or to any of the inactive ingredients
  • With cardiogenic shock
  • With second and third degree atrioventricular block - except in patients with a functioning artificial pacemaker
  • With sick sinus syndrome - except in patients with a functioning artificial pacemaker
  • With atrial fibrillation/flutter and concomitant Wolff-Parkinson-White syndrome
  • With existing history of angioedema associated with administration of an ACE inhibitor
  • With severe renal (creatinine clearance < 10 ml/min) or severe liver impairment (cirrhosis with ascites)
  • Pregnant women, women of childbearing potential who are unwilling to use contraception
  • Lactating women
  • Patients who have participated in clinical studies within the last month or who are currently enrolled in clinical studies
  • Patients currently treated with other fixed antihypertensive combination

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compliance With Tarka Treatment, All Participants and by Gender.Month 6 Visit

Participants were asked how many doses of Tarka they had missed since their previous visit.

Secondary Outcome Measures
NameTimeMethod
Change in Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)Baseline to Month 6 Visit

The mean (average) change in participants' systolic blood pressure and diastolic blood pressure from the baseline visit to the Month 6 visit.

Percentage of Patients Achieving Blood Pressure < 140/90 mmHgMonth 6 Visit

The percentage of patients who had achieved blood pressure less than 140/90 mmHg after six months of treatment.

Number and Type of Antihypertensive Drugs Added to Fixed Combination Tarka to Reach Blood Pressure GoalMonth 6 Visit

The number of participants at the Month 6 visit who were taking other antihypertensive drugs in addition to their Tarka treatment to reach a blood pressure goal of less than 140/90 mmHg. The number of participants taking each type of additional drug is summarized.

Adverse Events Leading to Study DiscontinuationBaseline to Month 6 Visit

The number of participants who discontinued from the study due to an adverse event and reported event descriptions are summarized.

Trial Locations

Locations (134)

Site Reference ID/Investigator# 40910

🇨🇿

Beroun, Czech Republic

Site Reference ID/Investigator# 42083

🇨🇿

Brumov, Czech Republic

Site Reference ID/Investigator# 38836

🇨🇿

Bystrice nad Pernstejnem, Czech Republic

Site Reference ID/Investigator# 41110

🇨🇿

Decin, Czech Republic

Site Reference ID/Investigator# 44896

🇨🇿

Babice, Czech Republic

Site Reference ID/Investigator# 40821

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 41196

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 41191

🇨🇿

Ceske Budejovice, Czech Republic

Site Reference ID/Investigator# 41197

🇨🇿

Hranice, Czech Republic

Site Reference ID/Investigator# 38816

🇨🇿

Blansko, Czech Republic

Site Reference ID/Investigator# 40944

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 41119

🇨🇿

Bustehrad, Czech Republic

Site Reference ID/Investigator# 38886

🇨🇿

Decin, Czech Republic

Site Reference ID/Investigator# 40805

🇨🇿

Hranice, Czech Republic

Site Reference ID/Investigator# 41113

🇨🇿

Kladno, Czech Republic

Site Ref # / Investigator 40961

🇨🇿

Krnov, Czech Republic

Site Reference ID/Investigator# 41192

🇨🇿

Kutna Hora, Czech Republic

Site Reference ID/Investigator# 41625

🇨🇿

Pardubice, Czech Republic

Site Reference ID/Investigator# 40900

🇨🇿

Plasy, Czech Republic

Site Reference ID/Investigator# 40822

🇨🇿

Prague 2, Czech Republic

Site Reference ID/Investigator# 41193

🇨🇿

Prague 6, Czech Republic

Site Reference ID/Investigator# 44884

🇨🇿

Prague 6, Czech Republic

Site Reference ID/Investigator# 40903

🇨🇿

Prague 8, Czech Republic

Site Reference ID/Investigator# 40802

🇨🇿

Prague 9, Czech Republic

Site Reference ID/Investigator# 40952

🇨🇿

Rokycany, Czech Republic

Site Ref # / Investigator 41626

🇨🇿

C. Trebova, Czech Republic

Site Reference ID/Investigator# 44887

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 41190

🇨🇿

Bystrice nad Pernstejnem, Czech Republic

Site Reference ID/Investigator# 40948

🇨🇿

Ceske Budejovice, Czech Republic

Site Reference ID/Investigator# 40960

🇨🇿

Ceske Budejovice, Czech Republic

Site Reference ID/Investigator# 42082

🇨🇿

Cheb, Czech Republic

Site Reference ID/Investigator# 40818

🇨🇿

Decin, Czech Republic

Site Reference ID/Investigator# 40815

🇨🇿

Hranice u Asa, Czech Republic

Site Reference ID/Investigator# 38736

🇨🇿

Jihlava, Czech Republic

Site Ref # / Investigator 38569

🇨🇿

Nymburk, Czech Republic

Site Reference ID/Investigator# 40949

🇨🇿

Olomouc, Czech Republic

Site Ref # / Investigator 40907

🇨🇿

Olomouc, Czech Republic

Site Reference ID/Investigator# 40957

🇨🇿

Pardubice, Czech Republic

Site Reference ID/Investigator# 40896

🇨🇿

Plzen, Czech Republic

Site Reference ID/Investigator# 40908

🇨🇿

Bilovec, Czech Republic

Site Reference ID/Investigator# 41189

🇨🇿

Brandys nad Labem, Czech Republic

Site Reference ID/Investigator# 40918

🇨🇿

Breclav, Czech Republic

Site Reference ID/Investigator# 41112

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 41187

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 40967

🇨🇿

Bruntal, Czech Republic

Site Reference ID/Investigator# 40914

🇨🇿

Ceske Budejovice, Czech Republic

Site Reference ID/Investigator# 57305

🇨🇿

Ceske Budejovice, Czech Republic

Site Reference ID/Investigator# 40897

🇨🇿

Decin, Czech Republic

Site Reference ID/Investigator# 41185

🇨🇿

Hradec Kralove, Czech Republic

Site Ref # / Investigator 44894

🇨🇿

Kladno, Czech Republic

Site Reference ID/Investigator# 40901

🇨🇿

Kunovice, Czech Republic

Site Ref # / Investigator 44882

🇨🇿

Mlada Boleslav, Czech Republic

Site Reference ID/Investigator# 40954

🇨🇿

Novy Jicin, Czech Republic

Site Reference ID/Investigator# 41202

🇨🇿

Orlova, Czech Republic

Site Reference ID/Investigator# 41194

🇨🇿

Ostrava, Czech Republic

Site Reference ID/Investigator# 41201

🇨🇿

Pardubice, Czech Republic

Site Reference ID/Investigator# 41205

🇨🇿

Pardubice, Czech Republic

Site Reference ID/Investigator# 40956

🇨🇿

Plzen, Czech Republic

Site Ref # / Investigator 46282

🇨🇿

Plzen, Czech Republic

Site Ref # / Investigator 40819

🇨🇿

Prague 4, Czech Republic

Site Reference ID/Investigator# 40817

🇨🇿

Prague 4, Czech Republic

Site Reference ID/Investigator# 44883

🇨🇿

Prague 5, Czech Republic

Site Ref # / Investigator 40807

🇨🇿

Stara Paka, Czech Republic

Site Reference ID/Investigator# 42085

🇨🇿

Stare Mesto, Czech Republic

Site Reference ID/Investigator# 41103

🇨🇿

Havirov, Czech Republic

Site Reference ID/Investigator# 40909

🇨🇿

Horni Slavkov, Czech Republic

Site Reference ID/Investigator# 38844

🇨🇿

Karlovy Vary, Czech Republic

Site Reference ID/Investigator# 41184

🇨🇿

Kdyne, Czech Republic

Site Reference ID/Investigator# 40905

🇨🇿

Koprivnice, Czech Republic

Site Reference ID/Investigator# 41114

🇨🇿

Olomouc, Czech Republic

Site Reference ID/Investigator# 41107

🇨🇿

Olomouc, Czech Republic

Site Reference ID/Investigator# 40968

🇨🇿

Ostrava, Czech Republic

Site Reference ID/Investigator# 40945

🇨🇿

Pardubice, Czech Republic

Site Reference ID/Investigator# 40812

🇨🇿

Prague 4, Czech Republic

Site Reference ID/Investigator# 41123

🇨🇿

Prague 8, Czech Republic

Site Ref # / Investigator 40820

🇨🇿

Teplice, Czech Republic

Site Reference ID/Investigator# 38739

🇨🇿

Trebic, Czech Republic

Site Reference ID/Investigator# 41200

🇨🇿

Trinec, Czech Republic

Site Reference ID/Investigator# 41182

🇨🇿

Uherske Hradiste, Czech Republic

Site Reference ID/Investigator# 40969

🇨🇿

Lovosice, Czech Republic

Site Reference ID/Investigator# 41204

🇨🇿

Mlada Boleslav, Czech Republic

Site Reference ID/Investigator# 40804

🇨🇿

Mnichovo Hradiste, Czech Republic

Site Ref # / Investigator 41118

🇨🇿

Novy Jicin, Czech Republic

Site Reference ID/Investigator# 38628

🇨🇿

Prague 5, Czech Republic

Site Reference ID/Investigator# 40823

🇨🇿

Prague 9, Czech Republic

Site Reference ID/Investigator# 41198

🇨🇿

Prelouc, Czech Republic

Site Reference ID/Investigator# 40809

🇨🇿

Pribram, Czech Republic

Site Reference ID/Investigator# 41109

🇨🇿

Slatinany, Czech Republic

Site Reference ID/Investigator# 41111

🇨🇿

Podebrady, Czech Republic

Site Reference ID/Investigator# 41120

🇨🇿

Prague 10, Czech Republic

Site Reference ID/Investigator# 41108

🇨🇿

Prague 2, Czech Republic

Site Reference ID/Investigator# 40917

🇨🇿

Prague 6, Czech Republic

Site Reference ID/Investigator# 40913

🇨🇿

Prague 8, Czech Republic

Site Reference ID/Investigator# 41124

🇨🇿

Prague 8, Czech Republic

Site Reference ID/Investigator# 38630

🇨🇿

Prague 9, Czech Republic

Site Reference ID/Investigator# 41126

🇨🇿

Prelouc, Czech Republic

Site Reference ID/Investigator# 44893

🇨🇿

Slany, Czech Republic

Site Reference ID/Investigator# 40919

🇨🇿

Smrzovka, Czech Republic

Site Reference ID/Investigator# 40814

🇨🇿

Stare Mesto, Czech Republic

Site Reference ID/Investigator# 41121

🇨🇿

Tabor, Czech Republic

Site Reference ID/Investigator# 41203

🇨🇿

Tranovice, Czech Republic

Site Reference ID/Investigator# 40970

🇨🇿

Trinec, Czech Republic

Site Reference ID/Investigator# 40895

🇨🇿

Trutnov, Czech Republic

Site Reference ID/Investigator# 41104

🇨🇿

Sternberk, Czech Republic

Site Reference ID/Investigator# 38746

🇨🇿

Svitavy, Czech Republic

Site Ref # / Investigator 40955

🇨🇿

Turnov, Czech Republic

Site Reference ID/Investigator# 40959

🇨🇿

Uherske Hradiste, Czech Republic

Site Reference ID/Investigator# 41116

🇨🇿

Usti nad Labem, Czech Republic

Site Reference ID/Investigator# 41186

🇨🇿

Zdar nad Sazavou, Czech Republic

Site Reference ID/Investigator# 42084

🇨🇿

Zdar nad Sazavou, Czech Republic

Site Reference ID/Investigator# 44895

🇨🇿

Zlonice, Czech Republic

Site Reference ID/Investigator# 40971

🇨🇿

Trinec, Czech Republic

Site Reference ID/Investigator# 40906

🇨🇿

Usti nad Labem, Czech Republic

Site Reference ID/Investigator# 41105

🇨🇿

Vyskov, Czech Republic

Site Ref # / Investigator 40958

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 40811

🇨🇿

Litomysl, Czech Republic

Site Reference ID/Investigator# 41106

🇨🇿

Litvinov, Czech Republic

Site Reference ID/Investigator# 40904

🇨🇿

Louny, Czech Republic

Site Reference ID/Investigator# 40953

🇨🇿

Malsice, Czech Republic

Site Reference ID/Investigator# 40951

🇨🇿

Ostrava, Czech Republic

Site Reference ID/Investigator# 40972

🇨🇿

Ostrava, Czech Republic

Site Ref # / Investigator 40911

🇨🇿

Prachatice, Czech Republic

Site Reference ID/Investigator# 40916

🇨🇿

Zamberk, Czech Republic

Site Reference ID/Investigator# 40950

🇨🇿

Valasske Mezirici, Czech Republic

Site Reference ID/Investigator# 40813

🇨🇿

Vyskov, Czech Republic

Site Ref # / Investigator 41115

🇨🇿

Zabreh, Czech Republic

Site Ref # / Investigator 38710

🇨🇿

Ceske Budejovice, Czech Republic

Site Reference ID/Investigator# 41195

🇨🇿

Bustehrad, Czech Republic

Site Ref # / Investigator 40902

🇨🇿

Decin, Czech Republic

Site Reference ID/Investigator# 41117

🇨🇿

Hadacka, Czech Republic

Site Reference ID/Investigator# 40808

🇨🇿

Havirov,Ostrava, Czech Republic

Site Reference ID/Investigator# 41188

🇨🇿

Hradec Kralove, Czech Republic

Site Reference ID/Investigator# 40816

🇨🇿

Ostrava, Czech Republic

Site Reference ID/Investigator# 44886

🇨🇿

Prague 3, Czech Republic

© Copyright 2025. All Rights Reserved by MedPath